Identification of Novel Marine-based Inhibitors against Tetracycline Destructase in Acinetobacter Baumannii using Computational Approaches
Sathish Kumar MarimuthuiD, Pratima Chockalingam, Vaishnavi Nagarajan, Subbiah ThamotharaniD, Vigneshwar RamakrishnaniD
Abstract
Tetracyclines are indispensable antibiotics employed to treat a broad spectrum of bacterial infections. However, the emergence of clinical pathogens exhibiting significant resistance to these drugs has posed a formidable challenge in managing bacterial diseases effectively. This resistance is attributed to the proliferation and diversity of resistance genes and various mechanisms that render tetracyclines inactive. A prevalent mechanism of resistance is enzymatic inactivation by tetracycline destructases, which compromises the efficacy of tetracyclines. Consequently, there is a pressing need to discover novel molecules capable of inhibiting tetracycline destructases activity and thereby enhancing the drugs potency. In this study, we identify novel inhibitors for tetracycline destructase (TDase) in Acinetobacter Baumannii, utilizing compounds derived from marine environments. Through a high-throughput virtual screening approach, we have investigated the potent natural marine compounds interaction and dynamic behaviour of tetracycline destructase through molecular simulations. These findings hold promise for the development of novel and efficacious therapeutics against bacterial infections.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Earliest observation of the tetracycline destructase tet(X3)
F. Grenier, S. Levesque, … L.-P. Haraoui·bioRxiv·Aug 29, 2023
- Antimicrobial activity of a repurposed harmine-derived compound on extensively drug-resistant Acinetobacter baumannii clinical isolates
A. Breine, M. Van Gysel, … C. Van der Henst·bioRxiv·Jun 30, 2021
- Molecular docking, validation, dynamic simulation and pharmacokinetic prediction of natural compounds against Mycobacterium tuberculosis Beta-lactamase BlaC
Sandra Sreekumar, J.L Bhagya Jyothi, … Immanuel Dhanasingh·bioRxiv·Jan 7, 2025
- Discovery of a novel antibiotic class targeting the enolase of Acinetobacterbaumannii
Irene Molina Panadero, Antonio Moreno Rodríguez, … Younes Smani·bioRxiv·Apr 23, 2025
- Bioactivity Analysis of Secondary Metabolites from Actinomycetes' Isolated from Coastal Sediments
Kumar Shubhro, Arifa Afrose Rimi, … SM Mahbubur Rahman·bioRxiv·Sep 8, 2024
- Venomics AI: a computational exploration of global venoms for antibiotic discovery
Changge Guan, Marcelo D. T. Torres, … César de la Fuente‐Núñez·Nature CommunicationsPeer-reviewed·Jul 12, 2025